BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11331441)

  • 1. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin inhibitor approved for anticoagulation during angioplasty.
    Lieder TR
    Am J Health Syst Pharm; 2001 Mar; 58(5):363. PubMed ID: 11258166
    [No Abstract]   [Full Text] [Related]  

  • 3. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalirudin: a direct thrombin inhibitor.
    Gladwell TD
    Clin Ther; 2002 Jan; 24(1):38-58. PubMed ID: 11833835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA panel votes against approval for bivalirudin.
    Piña I
    Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
    [No Abstract]   [Full Text] [Related]  

  • 6. Bivalirudin: a new generation antithrombotic drug.
    Scatena R
    Expert Opin Investig Drugs; 2000 May; 9(5):1119-27. PubMed ID: 11060732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.
    White HD
    Am Heart J; 2002 Feb; 143(2):189-92. PubMed ID: 11835018
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology and clinical use of bivalirudin.
    Sciulli TM; Mauro VF
    Ann Pharmacother; 2002 Jun; 36(6):1028-41. PubMed ID: 12022907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 10. Bivalirudin in peripheral interventions.
    Maclean AA; Peña CS; Katzen BT
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):80-3. PubMed ID: 17482105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin (Angiomax) use during intracoronary brachytherapy may predispose to acute closure.
    Sharma S; Bhambi B; Nyitray W; Desai K; Davis DL; Sharma G; Shukla P; File C; Ishimori T
    J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):9-15. PubMed ID: 12652325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Publication policy, informed consent, and the randomized clinical trial.
    Califf RM
    Am Heart J; 2002 Feb; 143(2):187-8. PubMed ID: 11835017
    [No Abstract]   [Full Text] [Related]  

  • 13. Caspofungin acetate, bivalirudin.
    Am J Health Syst Pharm; 2001 Oct; 58(19):1807-9. PubMed ID: 11596694
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bivalirudin as an anticoagulant during percutaneous coronary interventions in acute coronary syndromes: strengths and doubts].
    Savonitto S; Morici N
    Rev Esp Cardiol; 2011 May; 64(5):361-4. PubMed ID: 21482005
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
    Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
    Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin: a review.
    Warkentin TE; Koster A
    Expert Opin Pharmacother; 2005 Jul; 6(8):1349-71. PubMed ID: 16013985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalirudin in acute coronary syndromes.
    Sanmartin M
    N Engl J Med; 2007 Mar; 356(10):1069-70; author reply 1070-1. PubMed ID: 17347463
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
    Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
    J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: bivalirudin is a safe and effective anticoagulant in the percutaneous treatment of complex infrainguinal disease.
    Walker CM
    J Endovasc Ther; 2010 Feb; 17(1):37-8. PubMed ID: 20199264
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
    Levy JH
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.